Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Liechtenstein Times.
Orphan designation: Chimeric anti-interleukin-6 monoclonal antibody (siltuximab) Treatment of Castleman's disease, 30/11/2007 Expired
Overview On 30 November 2007, orphan designation (EU/3/07/508) was granted by the European Commission to Centocor, B.V., The Netherlands, for chimeric-anti-interleukin 6 monoclonal antibody for the treatment of Castleman's disease. Centocor B.V....
OSCE Calls for Gender-Balanced Political Representation and the Elimination of Gender-Based Violence
SARAJEVO, 6 June 2024 - The need for more gender-balanced political representation and the urgent need to end violence against women were key topics at the two-day regional expert conference titled Transforming Politics: Male Politicians as...
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine
If approved, IXCHIQ® will become the first vaccine available in the EU against the chikungunya virus (CHIKV) Decision on EU marketing authorization expected in the third quarter of 2024 Saint Herblain (France), May 31, 2024 – Valneva SE (Nasdaq:...
Mimo Announces the Launch of KUMA Interest Bearing Bond-Backed Tokens
Vaduz, Liechtenstein, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Decentralized Finance Innovator Mimo is launching “KUMA Protocol”: the first DeFi protocol issuing tokens backed by regulated NFTs, themselves backed by sovereign bonds. This launch comes as...
Joint Statement on Marking Two Years Since the Military Coup in Myanmar
A joint statement by the High Representative on behalf of the European Union, and the Foreign Ministers of Albania, Armenia, Australia, Bosnia and Herzegovina, Canada, the Federated States of Micronesia, Georgia, Ghana, Iceland, Liechtenstein,...
Monty Metzger‘s Book Released Today: Blockchain Banking - The Future of Money and Finance
Vaduz, Liechtenstein, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The book from entrepreneur and investor Monty C. M. Metzger is one part prophecy and future research report, one part documentation and case study, and one part survival manual about the...
OSCE Mission Workshop Promotes the Consistent Application of Intelligence-Led Policing to Enhance Crime Combat in BiH
A consistent application of intelligence-led policing (ILP) will ensure that Bosnia and Herzegovina (BiH) is well-equipped to effectively combat serious crime. To achieve this, the OSCE Mission to BiH organized a workshop in Mostar, gathering over...
Aurachain expands into Private Banking Sector and helps Sora Bank AG reduce loan processing time by up to 85%
SARNEN, Switzerland, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Aurachain, the low-code software development platform, has successfully enabled Sora Bank in Liechtenstein to reduce processing time on loans by up to 85% through a credit application – all in...
Hydroxyprogesterone caproate medicines to be suspended from the EU market
EMA’s safety committee, PRAC, has recommended the suspension of the marketing authorisations for medicines containing 17-hydroxyprogesterone caproate (17-OHPC) in the European Union (EU). A review by the PRAC concluded that there is a possible but...
OSCE and Council of Europe leadership stress the importance of strengthened co-operation to protect the principles and values of the Organizations
STRASBOURG, 17 May 2024 - The leadership of the Council of Europe and the Organization for Security and Co-operation in Europe met in Strasbourg on the margins of the 133rd Session of the Council of Europe’s Committee of Ministers in Strasbourg on...
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Allschwil, Switzerland, May 16, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the...
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
Positive opinion received from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for ONS-5010/LYTENAVA™ (bevacizumab gamma) United Kingdom (UK) Marketing Authorization Application (MAA) submitted NORSE...
State Auditor announces audit of the City of Joplin
State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska...
Talking Wood Studio, Award winning artisan bowl maker expands internationally to 108 Countries
Talking Wood Studio today announced the international expansion of its online store as it continues its mission to adorn the world’s finest tables. CANTON, GEORGIA, UNITED STATES, May 14, 2024 /EINPresswire.com/ -- Talking Wood Studio today...
Washington Fertility Center - 678931 - 04/30/2024
Delivery Method: VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED Reference #: 24-678931 Product: Biologics Recipient: Recipient Name Pierre Asmar, M.D. Recipient Title President and Medical Director Washington Fertility Center 4316 Evergreen Lane...
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
UK submission for national MAA review follows recently received positive opinion from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) concerning the authorization of ONS-5010/LYTENAVA™ (bevacizumab...
The Global Gin Industry Comes together for the Gin Guild’s Spring Installation in London
The world's leading gin distillers and industry professionals came together in for the Gin Guild’s Annual Gin Industry Dinner and Spring Installation LONDON, UNITED KINGDOM, May 8, 2024 /EINPresswire.com/ -- Gin distillers and industry...
Travere Therapeutics Reports First Quarter 2024 Financial Results
FDA grants Priority Review for sNDA to convert FILSPARI® (sparsentan) from accelerated approval to full approval for the treatment of IgAN in the U.S.; PDUFA target action date of September 5, 2024 Received 511 new patient start forms (PSFs) for...
Bridge Association Provides Free Educational Video-Tutorials for Artisans
A series of 15 video tutorials that want to support the professional training of SME entrepreneurs (especially those dealing with arts & crafts) were released! CLUJ-NAPOCA, TRANSYLVANIA, ROMANIA, April 30, 2024 /EINPresswire.com/ -- The series...
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade — — Positive opinion based on results from FRESCO-2 Phase III clinical...